News | Focused Ultrasound Therapy | February 16, 2021

Insightec plans to expand in Latin America through a partnership with Strattner

Insightec plans to expand in Latin America through a partnership with Strattner

February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by the Brazilian Health Regulatory Agency ANVISA (Agência Nacional de Vigilância Sanitária), and is partnering with Strattner to bring focused ultrasound to the Brazilian market.

This approval of the Exablate 4000 (Exablate Neuro) platform, which uses MR-guided focused ultrasound to precisely ablate tissue deep within the brain without incisions, will enable treatment for essential tremor and tremor-dominant Parkinson's Disease that has not responded to medications and neuropathic pain. 

Insightec is working with Strattner, a leading distributor of equipment for minimally invasive and robotic surgery, to reach leading medical centers and help advance adoption of focused ultrasound in the Brazilian market.  

"Leading neuroscience departments at medical centers around the globe recognize the value of adopting Focused Ultrasound as a treatment option for patient care. We are excited by the opportunities of expansion into Latin America," commented Maurice R. Ferré M.D., Insightec CEO and Chair of the Board of Directors.

Nearly 60 leading medical centers globally treat patients with debilitating hand tremor using Exablate Neuro. Performed in a single session in an MRI suite, many patients experience immediate tremor relief with minimal side effects.

"There are millions of Brazilians suffering from Essential Tremor or Tremor-dominant Parkinson's Disease and Exablate Neuro Focused Ultrasound has the potential to change their lives, through an incisionless procedure," said Felipe Strattner, Head of Strategy at Strattner. "We are eager to bring this transformational technology to medical centers across Brazil and help drive medicine forward in our country."

Exablate Neuro is the first and only focused ultrasound device approved by the U.S. Food and Drug Administration to treat medication-refractory Essential Tremor and Tremor-dominant Parkinson's Disease.

"Brazil represents a key strategic market in Latin America and this approval strongly positions Focused Ultrasound for future growth in the region," said J. Michael Quijano, Head of Strategic Partnerships & Business Development, Americas at Insightec.

For more information: www.insightec.com


Related Content

News | Point-of-Care Ultrasound (POCUS)

May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo ...

Time May 20, 2024
arrow
News | Cardiac Imaging

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | RSNA

May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of ...

Time May 07, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a ...

Time May 07, 2024
arrow
News | ARRS

May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...

Time May 07, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

May 6, 2024 — Hvidovre Hospital has the world's first prototype of a sensor capable of detecting errors in MRI scans ...

Time May 06, 2024
arrow
Subscribe Now